Health Canada has locked in a sweeping labelling overhaul for cosmetics. Beginning 12 April 2026, all manufacturers, brand owners, and businesses importing cosmetics into Canada must list a priority fragrance allergen on rinse-off products once it exceeds 0.01 %, while leave-on formulas trigger disclosure at just 0.001 %. The same allergens must also appear in the Cosmetic Notification Form, and the updated CNF now requires a Canadian mailing address for the manufacturer or importer. The aim is clear: align with EU transparency rules and let consumers spot potential irritants at a glance.
Key Milestones You Can’t Miss
- 12 April 2026 – All products, new or already on shelves, must declare the initial 24 EU-listed fragrance allergens when concentrations cross the new limits.
- 1 August 2026 – Any product launched after this date must disclose the full list of 81 allergens adopted from Europe.
- 1 August 2028 – The 81-allergen requirement applies to every cosmetic in Canada, no exceptions.
Miss a milestone and your shipment can stall at the border, face a recall, or rack up relabelling costs—none of which looks good on a balance sheet.
Step 1 – Audit Every Formulation
Gather complete ingredient decks
Pull the full INCI list for each SKU, including carrier solvents and any proprietary fragrance blends. This record becomes your compliance baseline.
Screen for allergens today, not tomorrow
Cross-reference every ingredient against the EU fragrance-allergen list—start with the core 24, then flag any of the additional 57 so you’re ready for 2026 and 2028 alike. Automated spreadsheet filters can cut this task from days to hours. ChemLinked
Verify concentrations with precision
Ask suppliers for Certificates of Composition that state exact percentages. If precise data aren’t available, record the updated CNF range codes. Exact figures still move your filing faster.
Log everything in a dedicated compliance folder
Store COAs, allergen declarations, and revision notes together. When Health Canada asks, you’ll have a tidy audit trail ready to share.
Flag at-risk products for reformulation early
If an allergen sits just above threshold, a minor tweak now beats an emergency label run later. Reach out to fragrance houses for lower-allergen alternatives before slots in their production calendar disappear.
With a thorough audit complete, you’ll know exactly which products need reformulation, which need only a label refresh, and which are already good to go—setting the stage for a smooth compliance journey.
Step 2 – Secure Updated Allergen Data From Suppliers
You can’t label what you don’t know, so start by tightening the information loop with every fragrance house and raw-material vendor. Ask for fresh Certificates of Composition that list all potential allergens and their exact percentages. If a supplier only offers range data, confirm that the ranges align with the new CNF codes—exact numbers still speed regulatory reviews. Push for documentation in both English and French to streamline downstream labelling. Finally, store every declaration in a single, version-controlled folder; it becomes your first-line defense during an inspection.
Step 3 – Refresh Labels for Full Compliance
Next, translate your audit findings onto the package. List each triggering allergen immediately after the word “Parfum/Fragrance,” and show the INCI name in both official languages. Keep font height above the minimum size—1.58 mm on containers under 120 mL—to stay readable at retail. Remember the thresholds: 0.01 % for rinse-off and 0.001 % for leave-on formulas. If any allergen knocks a product above those limits, adjust the deck before printing. Do a final press-proof to verify that French, English, and INCI spellings all match your supplier data exactly.
Step 4 – File an Updated Cosmetic Notification Form
Once the label is locked, turn to paperwork. Health Canada now requires a Canadian mailing address in Section 4 of the Cosmetic Notification Form—no P.O. boxes, and no overseas headquarters. Add every disclosed allergen to the ingredient list, using exact percentages or the approved concentration ranges. Submit the CNF within ten days of the product’s first sale—or immediately after a formula change—to avoid border delays or import holds. Keep a timestamped copy of the submission receipt in your compliance archive so you can prove timely filing if inspectors ask.
Step 5 – Prove Your Product Can Handle Real-World Conditions
Quality control can’t be an afterthought once the new labels land on shelves. Run accelerated-aging studies—heat-cycling, freeze/thaw, UV exposure—to confirm ink durability and formula stability after the added allergen disclosures. Use GC-MS or LC-MS to verify actual allergen concentrations in finished batches; this protects you if regulators challenge your numbers. Keep every lab report, chromatogram, and corrective-action note in the same compliance folder you built during the audit. Health Canada can request these files at any time, and under the Canada Consumer Product Safety Act you must retain documents for at least six years after the year they were created.
Step 6 – Train Your People and Fine-Tune Your Messaging
Everyone who touches the product—from R&D to warehouse pickers—needs to recognise the new allergen statements on sight.
- Regulatory and packaging teams run a brief on where allergens must sit in the INCI list and why bilingual accuracy matters.
- Marketing removes “fragrance-free” or “hypoallergenic” claims from any SKU that now discloses an allergen.
- Logistics updates SOPs so inbound QCs flag any shipment that arrives with outdated labels.
Early training avoids last-minute relabelled boxes piling up in the loading dock.
Enforcement & Penalties—Skip These, Sleep Better
Health Canada will take a “compliance-promotion” approach for the first 12 months after 12 April 2026. After that grace period ends in April 2027, inspectors can issue border holds, public recalls, or fines if they spot undeclared allergens or a missing Canadian address on the CNF. New launches that dodge the 1 August 2026 81-allergen rule could be refused entry outright, while legacy SKUs that miss the 1 August 2028 deadline risk costly shelf withdrawals. Staying ahead of the timeline keeps cash flowing and reputations intact.
Your Action Plan—Recap in Three Quick Moves
- Finish the formulation audit so you know every allergen and its exact or range concentration.
- Lock compliant labels and file the updated CNF well before the first milestone hits.
- Embed ongoing QC, record-keeping, and team training to sail through inspections without drama.
Need a Compliance Co-Pilot and Canadian Importer?
Progress Therapeutics guides importers through Cosmetic Notification Forms, bilingual label translations, and stability testing and can serve as your Canadian importer. Ready to stay ahead of the 2026 deadline? Book a call with our team today and keep your cosmetic launch on track.